Page last updated: 2024-08-21

hydrazine and Cytomegalovirus

hydrazine has been researched along with Cytomegalovirus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baer, P; Cinatl, J; Koch, B; Michaelis, M; Michel, D; Rabenau, H; Rothweiler, F; Schmidt, D; Schmidt, S; Stamminger, T; Vogel, JU1
Brighton, TA; Joseph, JE; Matthews, GV; Simpson, JD1

Other Studies

2 other study(ies) available for hydrazine and Cytomegalovirus

ArticleYear
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.
    Cells, 2019, 12-20, Volume: 9, Issue:1

    Topics: Animals; Benzoates; Cells, Cultured; Cytomegalovirus; Drug Synergism; Fibroblasts; Ganciclovir; Humans; Hydrazines; Iron Chelating Agents; Mesenchymal Stem Cells; Mice; NIH 3T3 Cells; Pyrazoles; Virus Replication

2019
Cytomegalovirus-associated thrombocytopenia treated with thrombopoietin receptor agonist.
    Internal medicine journal, 2016, Volume: 46, Issue:9

    Topics: Antiviral Agents; Benzoates; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Hydrazines; Middle Aged; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin

2016